Skip to content
Search

Latest Stories

Well Pharmacy urges older people and immunosuppressed patients to get their Covid boosters

Well Pharmacy is urging those eligible to take up the offer of a further Covid booster jab this spring.

Adults aged 75 years and over and anyone over 5 years old and are immunosuppressed – such as those who are undergoing chemotherapy or have had an organ transplant – are entitled to have a further Covid booster jab from mid-April, said one of the UK’s largest community pharmacy chains.


Taking part in the vaccination programme again, Well Pharmacy is encouraging people to book another booster as soon as they are contacted by the NHS – which should be at least six months after their previous booster.

The national booking site for those eligible opens this week.

The jabs have been updated since the vaccines were introduced to now target newer strains of Covid-19, Well said in a press release issued on Wednesday, 5 April.

Thousands of people are still testing positive for Covid each week according to Government data, and – while hospitalisations are down – a large number of people are still being hospitalised with Covid, so getting jabbed is as important as ever.

And the Joint Committee on Vaccination and Immunisation (JCVI) recently confirmed that hospital admissions last autumn highlighted that the risk of becoming seriously ill from coronavirus was noticeably higher in people over 75.

George Sandhu, deputy superintendent pharmacist at Well Pharmacy, said: “While – happily – we are in a very different place nationally to where we once were on Covid, it hasn’t gone away.

“Thousands of people are still testing positive each week, so if you’re at greater risk of getting poorly as a result of catching Covid then it’s important to give yourself as much protection as possible. With the ever-changing covid situation, we would highly recommend people don’t delay in getting their booster. It is the best and safest way of protecting yourself and your loved ones, with the jab protecting against different variants of the virus."

Calling on those interested, he added: “Make sure you book your appointment as soon as you are contacted by the NHS, either online or by calling 119. We hope to see some of you in our pharmacies soon. If you have any questions, our pharmacy teams will be more than happy to assist you.”

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less